Insider · CIK 0001679076

Lo Andrew

Reports to the SEC for 7 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001679076

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,277 sh	—	—	5,277
2026-06-22	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+3,990 sh	—	—	18,079
2025-11-18	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−24K sh	$65.23	−$1.57M	81,576
2025-11-18	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−31K sh	$66.05	−$2.05M	50,583
2025-11-17	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−36.8K sh	$66.63	−$2.45M	17,887
2025-11-17	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−3,798 sh	$67.06	−$255K	14,089
2025-06-20	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+6,589 sh	—	—	54,688
2025-06-20	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,425 sh	—	—	8,425
2025-06-12	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director	AAward	+239K sh	—	—	541,354
2025-05-02	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−100K sh	$38.50	−$3.85M	105,583
2024-06-21	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director	AAward	+164K sh	—	—	302,490
2024-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,014
2023-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.5K sh	—	—	51,501
2022-12-01	ABCLAbCellera Biologics Inc. · Share Option (right to buy)A Award	Director	AAward	+47.2K sh	—	—	138,556
2022-09-15	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+71.9K sh	—	—	71,850
2022-09-15	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+52.1K sh	—	—	52,142
2022-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+105K sh	—	—	104,921
2021-12-30	BBIOBridgeBio Pharma, Inc.P Purchase	Director	PPurchase	+1,500 sh	$14.30	+$21.5K	48,099
2021-12-29	BBIOBridgeBio Pharma, Inc.P Purchase	Director	PPurchase	+6,000 sh	$12.90	+$77.4K	46,599
2021-12-03	ABCLAbCellera Biologics Inc. · Share Option (right to buy)A Award	Director	AAward	+91.3K sh	—	—	91,325
2021-12-03	ABCLAbCellera Biologics Inc.P Purchase	Director	PPurchase	+86.9K sh	$14.02	+$1.22M	86,938
2021-06-17	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+38.9K sh	—	—	38,895
2020-06-23	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,223
2019-06-19	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+4,957 sh	$8.17	+$40.5K	22,860,013
2019-06-18	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,706 sh	$8.21	+$55.1K	22,855,056
2019-06-17	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,541 sh	$8.53	+$55.8K	22,848,350
2019-06-14	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,144 sh	$7.91	+$56.5K	22,841,809
2019-06-13	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,367 sh	$7.95	+$58.5K	22,834,665
2019-06-12	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,500 sh	$8.30	+$62.2K	22,827,298
2019-06-11	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,189 sh	$8.58	+$61.7K	22,819,798
2019-06-10	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,500 sh	$8.35	+$62.6K	22,812,609
2019-06-07	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,649 sh	$7.96	+$53K	22,805,109
2019-06-06	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,082 sh	$8.00	+$56.6K	22,798,460
2019-06-05	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,540 sh	$8.02	+$52.4K	22,791,378
2019-06-04	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+7,500 sh	$7.59	+$56.9K	22,784,838
2019-06-04	Myovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+2.42M sh	$8.25	+$20M	40,765,599
2019-06-03	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,424 sh	$7.71	+$41.8K	22,777,338
2019-05-31	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,071 sh	$7.70	+$39K	22,771,914
2019-05-30	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,951 sh	$7.97	+$55.4K	22,766,543
2019-05-30	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+300 sh	$8.91	+$2,671.98	22,766,843
2019-05-29	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,882 sh	$7.55	+$52K	22,759,592
2019-05-28	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+3,807 sh	$7.68	+$29.2K	22,752,710
2019-05-24	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+3,796 sh	$7.70	+$29.2K	22,748,903
2019-05-23	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+4,802 sh	$7.76	+$37.3K	22,745,107
2019-05-22	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,033 sh	$8.06	+$40.6K	22,740,305
2019-05-21	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+9,995 sh	$8.52	+$85.1K	22,735,272
2019-05-20	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+8,285 sh	$7.98	+$66.1K	22,723,562
2019-05-20	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+1,715 sh	$8.39	+$14.4K	22,725,277
2019-05-17	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+6,200 sh	$7.36	+$45.6K	22,715,277
2019-05-16	Urovant Sciences Ltd.P Purchase	Former 10% Owner	PPurchase	+5,408 sh	$6.79	+$36.7K	22,709,077

Recent filings

Accepted (ET)
Jun 244
Lo Andrew0001470831-26-000634
SEC(opens sec.gov)
Nov 194
Lo Andrew0001470831-25-000357
SEC(opens sec.gov)
Jun 244
Lo Andrew0000950170-25-089674
SEC(opens sec.gov)
Jun 164
Lo Andrew0001628280-25-031646
SEC(opens sec.gov)
May 64
Lo Andrew0000950170-25-064558
SEC(opens sec.gov)
Jun 254
Lo Andrew0000950170-24-077446
SEC(opens sec.gov)
Jun 244
Lo Andrew0001628280-24-029668
SEC(opens sec.gov)
Jun 234
Lo Andrew0001209191-23-039385
SEC(opens sec.gov)
Dec 54
Lo Andrew0001209191-22-059580
SEC(opens sec.gov)
Sep 194
Lo Andrew0001140361-22-033876
SEC(opens sec.gov)
Jun 244
Lo Andrew0001209191-22-039256
SEC(opens sec.gov)
Jan 34
Lo Andrew0000899243-22-000188
SEC(opens sec.gov)
Dec 104/A
Lo Andrew0001209191-21-068976
SEC(opens sec.gov)

Companies

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304